According to the latest filing from the U.S. Securities and Exchange Commission (SEC), biotechnology company Regenxbio Inc has officially signed a settlement and release agreement with pharmaceutical giant GlaxoSmithKline.

According to the latest filing from the U.S. Securities and Exchange Commission (SEC), biotechnology company Regenxbio Inc has officially signed a settlement and release agreement with pharmaceutical giant GlaxoSmithKline.

老虎证券2026/03/20 21:33

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The agreement will take effect on March 18, 2026, marking a final resolution between both parties regarding the related disputes. The signing of this agreement terminates the previous legal disputes between the two parties, clearing obstacles for potential future cooperation. The document does not disclose the specific settlement amount or details of the agreement, but it clearly states that both parties agree to waive all claims against each other in this matter.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The average bond financing cost premium for US investment-grade technology company borrowers, compared to the overall US market, has reached its highest level since 2003. Analysts point out that as financing supply continues to expand, the spread on US technology bonds may widen further. US technology companies are seeking to diversify their massive funding needs through different currencies and markets. BNP Paribas expects the net supply of investment-grade corporate bonds in the Eurozone to increase by 83% by 2027.

华尔街见闻•2026/11/03 18:16

BUZZ-Revvity’s third-quarter results surpass expectations, stock poised for best single-day performance in 16 years

路透社•2026/11/03 18:11

Food distributor Sysco says that the outbreak of cyclosporiasis has affected its first-quarter sales

路透社•2026/11/03 18:06

Correction - Updated version: 2-Keurig Dr Pepper indicates that fourth-quarter coffee business profit growth slowed as consumers shifted to lower-priced products.

路透社•2026/11/03 17:56